UMIN-ICDS Clinical Trial

Unique ID issued by UMIN UMIN000052390
Receipt number R000059800
Scientific Title Effect of Daily Ingestion of "from Banana" on bowel movements in healthy volunteers -A Randomized, Double-blind, Cross-over, Placebo-controlled Study-
Date of disclosure of the study information 2023/10/05
Last modified on 2023/10/03 18:03:35

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Effect of Daily Ingestion of "from Banana" on bowel movements

Acronym

Effect of Ingestion of "from Banana" on bowel movements

Scientific Title

Effect of Daily Ingestion of "from Banana" on bowel movements in healthy volunteers -A Randomized, Double-blind, Cross-over, Placebo-controlled Study-

Scientific Title:Acronym

Effect of Daily Ingestion of "from Banana" on bowel movements in healthy volunteers

Region

Japan


Condition

Condition

Healthy adults

Classification by specialty

Adult

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To evaluate the effects of daily ingestion of "From Banana" on bowel movements

Basic objectives2

Safety,Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

stool shape, stool color, intensity of stool odor, feeling after defecation, defecation volume, defecation frequency, farts frequency, number of days of defecation before and 2weeks after intake

Key secondary outcomes

Diary on health condition


Base

Study type

Interventional


Study design

Basic design

Cross-over

Randomization

Randomized

Randomization unit

Individual

Blinding

Double blind -all involved are blinded

Control

Placebo

Stratification

YES

Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

3

Purpose of intervention

Treatment

Type of intervention

Food

Interventions/Control_1

2-weeks intake of "From Banana" 10g/day

Interventions/Control_2

2-weeks intake of "From Banana" 5g/day and Placebo 5g/day

Interventions/Control_3

2-weeks intake of Placebo 10g/day

Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

59 years-old >=

Gender

Male and Female

Key inclusion criteria

1) Japanese males and females aged 20 to 59 years oldĀ at the time of informed consent
2) Those who defecate 3 to 5 times per week
3) Those whose life cycle is relatively stable, with no extreme fluctuations in meal times or sleeping hours throughout the week
4) Those who do not skip breakfast and eat three meals a day

Key exclusion criteria

1) Those who daily intake supllements that may affect the test results such as lactic acid bacteria or oligosaccharides
2) Those with severe anemia
3) Those who eat sweets or nutritional jelly instead of meals
4) Those who actively intake fermented foods such as yogurt, kimchi or natto
5) Those who eat more than 5 bananas a week
6) Those who intend to eat a vegetable-centered diet
7) Those who intake medications that may affect the test results such as antibiotics or medications with intestinal regulating effects
8) Those who may be allergic to the test product ingredients
9) Those who are participating in other clinical trials
10) Patients who suffer from a specific disease and are undergoing hospital visits, medication, or treatments
11) Pregnant, possibly pregnant or lactating
12) Persons who are alcoholics
13) Persons with a history of serious hepatic disorder, renal disorder, or cardiac disease
14) Persons with a history or current illness of hepatitis

Target sample size

30


Research contact person

Name of lead principal investigator

1st name Takashi
Middle name
Last name Koikeda

Organization

Shiba Palace Clinic

Division name

Chair

Zip code

105-0013

Address

DaiwaA Hamamatsucho Bldg. 6F, 1-9-10, Hamamatsucho, Minato-ku, Tokyo, 105-0013, JAPAN

TEL

03-5408-1590

Email

jimukyoku@mail.souken-r.com


Public contact

Name of contact person

1st name Ko
Middle name
Last name Masuda

Organization

SOUKEN Co., Ltd

Division name

Management Division

Zip code

105-0013

Address

DaiwaA Hamamatsucho Bldg. 3F, 1-9-10, Hamamatsucho, Minato-ku, Tokyo, 105-0013, JAPAN

TEL

03-5408-1555

Homepage URL


Email

k_masuda@mail.souken-r.com


Sponsor or person

Institute

Shiba Palace Clinic

Institute

Department

Personal name



Funding Source

Organization

White from green Inc.

Organization

Division

Category of Funding Organization

Profit organization

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Shiba Palace Clinic Ethics Review Committee

Address

DaiwaA Hamamatsucho Bldg. 6F, 1-9-10, Hamamatsucho, Minato-ku, Tokyo, 105-0013, JAPAN

Tel

03-5408-1599

Email

shiba_palace@s-palace-clinic.com


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2023 Year 10 Month 05 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled

32

Results

Defecation volume significantly increased after 2-weeks of intake in the 10g FromBanana group.

Results date posted

2023 Year 10 Month 03 Day

Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2022 Year 07 Month 13 Day

Date of IRB

2022 Year 08 Month 09 Day

Anticipated trial start date

2022 Year 09 Month 14 Day

Last follow-up date

2023 Year 02 Month 10 Day

Date of closure to data entry

2023 Year 02 Month 20 Day

Date trial data considered complete

2023 Year 02 Month 28 Day

Date analysis concluded

2023 Year 04 Month 01 Day


Other

Other related information



Management information

Registered date

2023 Year 10 Month 03 Day

Last modified on

2023 Year 10 Month 03 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000059800


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name